<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3DEC667A-ED1D-4DA4-8115-93831987CDA4"><gtr:id>3DEC667A-ED1D-4DA4-8115-93831987CDA4</gtr:id><gtr:name>Hospital Covadonga Oviedo</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CF8C18F2-38A1-4EA5-9D3C-377C679C83BD"><gtr:id>CF8C18F2-38A1-4EA5-9D3C-377C679C83BD</gtr:id><gtr:name>National Centre for Biological Science (NCBS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:department>Finance</gtr:department><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03D8AFBB-3EA5-4885-B036-BD4F9F4F9849"><gtr:id>03D8AFBB-3EA5-4885-B036-BD4F9F4F9849</gtr:id><gtr:name>University of Sheffield</gtr:name><gtr:address><gtr:line1>Firth Court</gtr:line1><gtr:line2>Western Bank</gtr:line2><gtr:line4>Sheffield</gtr:line4><gtr:line5>South Yorkshire</gtr:line5><gtr:postCode>S10 2TN</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9E6E29A1-FFE3-487C-84F6-02CD1B6E313A"><gtr:id>9E6E29A1-FFE3-487C-84F6-02CD1B6E313A</gtr:id><gtr:name>National Institute for Biological Standards and Control (NIBSC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3DEC667A-ED1D-4DA4-8115-93831987CDA4"><gtr:id>3DEC667A-ED1D-4DA4-8115-93831987CDA4</gtr:id><gtr:name>Hospital Covadonga Oviedo</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB"><gtr:id>AE6EAB1A-CC2F-4FDB-A57F-41E76D78ACAB</gtr:id><gtr:name>Oxford University Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Churchill Site</gtr:line1><gtr:line2>Old Road</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX3 7LJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CF8C18F2-38A1-4EA5-9D3C-377C679C83BD"><gtr:id>CF8C18F2-38A1-4EA5-9D3C-377C679C83BD</gtr:id><gtr:name>National Centre for Biological Science (NCBS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D739677A-6514-46E5-821F-22EEA573D62A"><gtr:id>D739677A-6514-46E5-821F-22EEA573D62A</gtr:id><gtr:name>University of Ghent</gtr:name><gtr:address><gtr:line1>Rectorate Building</gtr:line1><gtr:line2>Sint-Pietersnieuwstraat 25</gtr:line2><gtr:line3>Krijgslaan</gtr:line3><gtr:postCode>B-9000</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CDF99109-6551-4702-82BE-688365A28487"><gtr:id>CDF99109-6551-4702-82BE-688365A28487</gtr:id><gtr:firstName>Harry</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Moore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9DD0CDDD-B985-4282-BFBA-3EAD976B1EEB"><gtr:id>9DD0CDDD-B985-4282-BFBA-3EAD976B1EEB</gtr:id><gtr:firstName>Darren</gtr:firstName><gtr:surname>Shickle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C1DF0C94-7231-422A-8C61-C85A8BD4D3EF"><gtr:id>C1DF0C94-7231-422A-8C61-C85A8BD4D3EF</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:otherNames>Walter</gtr:otherNames><gtr:surname>Andrews</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300273"><gtr:id>3A2303FF-AE27-4DF7-858D-2482084003D2</gtr:id><gtr:title>Proposal for a Human Embryonic Stem (ES) Cell Resource Centre</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300273</gtr:grantReference><gtr:abstractText>We aim to provide resources and training for other researchers planning to take up the study of human embryonic stem (ES) cells. At the same time we plan to develop new underpinning technologies to help facilitate research with these cells.
ES cells are derived from early human embryos and have the capacity to grow indefinitely in culture. At the same time they retain the ability to differentiate, or change, into all of the different cell types found in the human body. It is hoped can use this capacity of ES cells to develop new sources of cell types for replacing diseased or damaged tissues, or to develop new tools for understanding human development and the causes or different diseases.
The human ES cell field is young and the techniques for working with these cells are poorly developed. By providing resources for training investigators new to human ES cell research, and establishing new tools, we will help increase the capacity for new research that will underpin the future applications of human ES cells.
.</gtr:abstractText><gtr:technicalSummary>We propose to establish a Human ES Cell Resource Centre to help accelerate progress with human Embryonic Stem (hES) cell research in the UK, by making readily available qualified to UK researchers human ES cell resources and expertise currently held in the Centre for Stem Cell Biology of the University of Sheffield. In particular, the Resource Centre would: i) provide rapid access to expertise and facilities to support short term pilot projects in hES cell biology, designed to obtain proof of concept and preliminary data to underpin further grant applications, ii) offer training in working with hES cells, iii) make the infrastructure for hES cell work available to specific, funded collaborative projects with researchers who have expertise and interests in other areas pertinent to hES cell research and its application, but who do not wish to establish that infra-structure themselves, iv) develop specific hES cell technologies that can be made available to the UK research community as a whole, v) set up, in conjunction with the National Stem Bank, a website and database, to collate and provide ready access to technical information and protocols developed in the Centre, and elsewhere, pertinent to future hES cell research, and vi) establish a program to evaluate the economic and social factors that will influence the future development of clinical applications of hES based research, including the public perception and ethical acceptability of current hES research and the potential economic impact in relation to different disease and patient groups. Technologies developed in the Centre would include: i) cryopreservation, ii) optimization of culture conditions and growth without feeders, iii) development of RNAi technologies for hES cells, iv) development of vectors to allow production of stable constitutive and conditional transfectants, v) development of homologous recombination strategies, and vi) development of new monoclonal antibodies to marker antigens for hES cells and their differentiated derivatives.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>955313</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oxford University Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Enver - behaviour of hES cells</gtr:description><gtr:id>D0747598-E5C9-4945-8D35-2485D255ACA1</gtr:id><gtr:impact>Enver T, Soneji S, Joshi C, Iborra F, Orntoft T, Thykjaer T, Maltby E, Smith K, Abu Dawd R, Matin M, Gokhale P, Draper JS, Andrews PW (2005) Cellular differentiation hierarchies in normal and culture adapted human embryonic stem cells. Human Mol Genet. 14: 1-12.</gtr:impact><gtr:outcomeId>D341FA19ED7-1</gtr:outcomeId><gtr:partnerContribution>Analysis of the behaviour of stem cells.</gtr:partnerContribution><gtr:piContribution>The work has led to the analysis of the behaviour of hES cells and their adaptation to culture, which has parallels with cancer development from stem cells. We have been able to assist Prof. Enver in establishing his own hES cell program for CSCB has provided training, protocols and materials (eg. feeder cells, antibodies, etc).</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital Covadonga Oviedo</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Immunology Service</gtr:department><gtr:description>Suarez - project on epigenetic regulation</gtr:description><gtr:id>6AD23E4B-559F-44FA-BA40-AA4C6431F8E8</gtr:id><gtr:impact>PMID 188207279</gtr:impact><gtr:outcomeId>5840E87DC11-1</gtr:outcomeId><gtr:partnerContribution>A project was initiated focusing on epigenetic regulation of MHC expression and regulation in hES cells.</gtr:partnerContribution><gtr:piContribution>Dr Suarez attended a training day held at CSCB where staff provided advice, training and expertise in working with hES cells.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Centre for Biological Science (NCBS)</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>NCBS, India - hES cell training course</gtr:description><gtr:id>34950F8B-A6A1-4985-A099-48E889E39897</gtr:id><gtr:impact>Collaboration continues and in part supported by a UKIERI award. A member of the India team is expected to spend up to 3 months in Sheffield before the end of 2010.</gtr:impact><gtr:outcomeId>961612C476D-1</gtr:outcomeId><gtr:partnerContribution>Interactions have led to continued dialogue and establishment of an on-going collaboration funded by a UKIERI grant.</gtr:partnerContribution><gtr:piContribution>Staff members of CSCB have contributed to two practical courses in working with hES cells, held at the NCBS, the first sponsored by the Royal Society and the FCO. A member of this group has spent 12 days at NCBS, helping with cell culture techniques and growing hES cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ghent</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Timmermans &amp;amp; Vandekerckhove - Generation of T cells</gtr:description><gtr:id>DC8C5534-978F-4674-AFD9-89C0EA571883</gtr:id><gtr:impact>Paper submitted.</gtr:impact><gtr:outcomeId>A8979888320-1</gtr:outcomeId><gtr:partnerContribution>Collaborations on the generation of T cells in vitro from hES cells.</gtr:partnerContribution><gtr:piContribution>Staff worked together, offering advice and expertise.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ophthalmology UCL</gtr:department><gtr:description>Coffey - hES cells to retinal pigment cells</gtr:description><gtr:id>0B61D304-91D0-4CBF-93A9-BF963CC7137C</gtr:id><gtr:impact>Collaboration with Prof. Coffey has led to the recognition that hES cells can readily differentiate to retinal pigment cells that potentially can be used for transplantation to cure macular degeneration. Prof. Coffey is using hEScells developed at the Centre for Stem Cell Biology for these experiments aimed at eventual clinical trials. Staff from CSCB have contributed expertise and reagents, etc as well as training to support his on-going work.</gtr:impact><gtr:outcomeId>9B13F78054A-1</gtr:outcomeId><gtr:partnerContribution>Using hES cells developed at CSCB.</gtr:partnerContribution><gtr:piContribution>Using hES cells developed at CSCB.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Biological Standards and Control (NIBSC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lotte - Relationships between hES &amp;amp; EC cells</gtr:description><gtr:id>0C891A9F-A63B-4833-9012-BA0C734C17D0</gtr:id><gtr:impact>Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O, Kallioniemi O, Lothe RA. 2006 Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol. 28:315-326</gtr:impact><gtr:outcomeId>4F7EE50CD10-1</gtr:outcomeId><gtr:partnerContribution>Exploring relationships between hES and embryonal carcinoma (EC) cells from germ cell tumours.</gtr:partnerContribution><gtr:piContribution>The project is facilitated by the infrastructure of the CSCB, notably from the panel of human EC cells that are maintained in Sheffield, as well as antibodies, reagents and panel of hES cell lines.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>Dunne - Development of pancreatic cells for treating diabetes</gtr:description><gtr:id>96653DC2-550C-4122-9976-B2D9E496C708</gtr:id><gtr:impact>PMID 18335054</gtr:impact><gtr:outcomeId>34E2C73F74E-1</gtr:outcomeId><gtr:partnerContribution>Joint grant from JDRF supported the development of basic aspects of hES cell biology.</gtr:partnerContribution><gtr:piContribution>Funds were jointly awarded by the JDRF to develop basic aspects of hES cell biology that could eventually facilitate their use in developing pancreatic cells for treatment of disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Biological Standards and Control (NIBSC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UK Stem Cell Bank</gtr:department><gtr:description>Cell banking</gtr:description><gtr:id>FB0BC2A4-A9CC-4189-BC5A-5B9D79BD61EE</gtr:id><gtr:impact>Successful annual training events have been held and substantial other collaborations have resulted from UKSCB involvement. PMID: 17572666.</gtr:impact><gtr:outcomeId>E532DB68CD4-1</gtr:outcomeId><gtr:partnerContribution>Shared expertise and knowledge of working with hES cells.</gtr:partnerContribution><gtr:piContribution>Close interaction with UKSCB to facilitate the spread of expertise with human ES cell culture. Members of UKSCB have taught on training courses and staff members at Sheffield have provide advice with the UKSCB activities.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ESTOOLS Annual Public Meeting, Brno</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>FAA999D8-D56E-466C-9D06-FC393C7973C1</gtr:id><gtr:impact>Public meeting held at the end of the ESTOOLS FP6 project Annual Meeting, attended by 150 members of the public, mainly from local Czech people but also invited speakers and members of the consortium. 1 day meeting. Positive feedback - recorded on the ESTOOLS website www.estools.org.

The interest generated by those attendance has proven the need for more events such as this, to keep the public informed. Also broadcast through Czech TV and radio coverage.</gtr:impact><gtr:outcomeId>6F128D21917</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science week activities</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>1B9DC1A6-A144-42E1-B383-100A41C3BA60</gtr:id><gtr:impact>Staff giving lectures, workshops and presentations in schools.

Unknown</gtr:impact><gtr:outcomeId>B27E8829676</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Sheffield</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E16E7680-D586-49B0-9AD2-BFCF77712BD2</gtr:id><gtr:impact>Talks given on stem cells and what they are, the derivation of hES cells, international aspects of science and undergraduate degrees at the University of Sheffield, followed by demonstrations and tour of lab facilities.

Further request to do the same in the next year as the pupils found it of benefit.</gtr:impact><gtr:outcomeId>15AB413C223</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local school visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>CE8779A4-572E-4B93-8CA9-291492F44B46</gtr:id><gtr:impact>Attended by 25 school children aged 16. Talks given on stem cells and what they are, the derivation of hES cells, international aspects of science and undergraduate degrees at the University of Sheffield, followed by demonstrations and tour of lab facilities.

Provided information on human ES cell research to local Sheffield High School students</gtr:impact><gtr:outcomeId>EA31D3CEF30</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Euronews broadcast</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>FEFA16F8-0AE3-4E7C-B7F3-BEE0500E3E32</gtr:id><gtr:impact>Interview held with PI and MEP on working with human embryonic stem cells, broadcasted by Euronews, Brussels.

Link to European Parliament</gtr:impact><gtr:outcomeId>2CB288AE3BF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media (as a channel to the public)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>834354E9-37B8-4536-B82F-72AC068FD12F</gtr:id><gtr:impact>Cooperation with representatives of the media, provided interviews and information, partly through the Science Media Centre, to inform journalists of the work.

Unknown</gtr:impact><gtr:outcomeId>4E2AE979B66</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F69948F4-C768-4240-865B-8B9404C2F09B</gtr:id><gtr:impact>Presentations and posters given at this event, aimed primarily at pupils from schools and colleges in the local area, promoting a career in science. 5 day event. Positive feedback from students.

Information provided to high school students</gtr:impact><gtr:outcomeId>0E2EF0E4417</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Espergaerde Upper Secondary School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>7DA7B015-70C0-4EB1-9393-ED471EC2350B</gtr:id><gtr:impact>Attended by 22 school-aged children from a school in Denmark where a series of short talks, and question/answer sessions were held. Positive feedback from both pupils and teachers.

Provided information on human ES cell research to a visiting class of Danish High School students</gtr:impact><gtr:outcomeId>67C7FCE2673</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ESTOOLS Annual Public Meeting, Budapest</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>058838AE-0427-4615-87A3-F716B5D1616A</gtr:id><gtr:impact>Annual Scientific Meeting of ESTOOLS an FP6 Consortium co-ordinated by the PI and CSCB in Sheffield

Public meeting held at the end of the ESTOOLS FP6 project Annual Meeting, attended by 150 members of the public, mainly from local Hungarian people but also invited speakers and members of the consortium. 1 day meeting. Positive feedback - recorded on the ESTOOLS website www.estools.org. Conveyed information on human ES cell research to non-scientists in Hungary.</gtr:impact><gtr:outcomeId>FB182984BF3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit - Denmark school</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>FCE8117C-96C2-48CF-A614-BA0298BBDFFF</gtr:id><gtr:impact>Visit by a group of 22 children from an upper secondary school.

Unknown</gtr:impact><gtr:outcomeId>722D518CBFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>427826</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ESTOOLS Advances with Human Embryonic Stem Cells (12m euros across 23 participants)</gtr:description><gtr:end>2010-07-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E4F14724-A96C-46D6-BD1B-BBCC2A6F3063</gtr:id><gtr:outcomeId>7EA999175390</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1368610</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B6C3C1AB-DAC9-404A-BDFD-AA85C276AA86</gtr:id><gtr:outcomeId>949C644DB500</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>112500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UKIERI Collaboration grant</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>UK-India Education and Research Initiative (UKIERI)</gtr:fundingOrg><gtr:id>F4BAFF82-A6C3-4A97-A794-79ABB432D399</gtr:id><gtr:outcomeId>7A36882C6900</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>265737</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant (Identifying chemical agents that affect human embryonic stem cells in vitro and determining their molecular targets)</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>0C49EDEA-BB56-44A7-8903-A3BB3D423828</gtr:id><gtr:outcomeId>AA274A091450</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2006-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>215030</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>CFD5E728-910D-4F0F-97E4-65861ED8DDB5</gtr:id><gtr:outcomeId>550B2B30B620</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>166700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>YCR Project Grant</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Yorkshire Cancer Research</gtr:fundingOrg><gtr:id>C40FC245-E4B5-46B6-B9BA-0CF5803674EA</gtr:id><gtr:outcomeId>A514854B9A20</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1080000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/ISCF</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FB33B857-D57C-4CAD-B1D2-93CD06B60040</gtr:id><gtr:outcomeId>1221AFEF7090</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Human ES cell lines containing and expressing various transgenes including GFP and the tetrocyclin repressor protein</gtr:description><gtr:id>48B8CBDD-3795-4F63-8882-9E88AB0FC4E5</gtr:id><gtr:impact>Tet-repressor sysgem is available for inducible knock-down of genes using shRNA</gtr:impact><gtr:outcomeId>BE6FCF11B44</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genetically modified human ES cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Two new human ES cell lines were developed, Shef3 and Shef6</gtr:description><gtr:id>1B57F696-17E5-4A9A-B386-FF6CBC1D6C0B</gtr:id><gtr:impact>Human ES cell lines deposited to UK Stem Cell Bank and available for human ES cell research</gtr:impact><gtr:outcomeId>9B6A6211F0C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human ES cells</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9623EC41-CEE0-47E4-9C3B-DC101A3867CE</gtr:id><gtr:title>Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13336df85d65ae458beb66af5ae249f"><gtr:id>b13336df85d65ae458beb66af5ae249f</gtr:id><gtr:otherNames>Fox V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>iDQ1XbqULib</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55FA5AFF-2577-4023-A97F-64F808ECEBEC</gtr:id><gtr:title>Transient and stable transgene expression in human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d35b264e78cb1334ae29357e5f8511b"><gtr:id>2d35b264e78cb1334ae29357e5f8511b</gtr:id><gtr:otherNames>Liew CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>Xa1Nj8j15UV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>992A676D-14A9-41EA-AC97-AC29567D7EA9</gtr:id><gtr:title>Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84acd4e7a4e0b8479133f035aae2263d"><gtr:id>84acd4e7a4e0b8479133f035aae2263d</gtr:id><gtr:otherNames>Harun R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>08C930AB536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F761EFD-F37A-4B98-BCE7-2804382AE288</gtr:id><gtr:title>Stem cell therapy to treat diabetes mellitus.</gtr:title><gtr:parentPublicationTitle>The review of diabetic studies : RDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d35b264e78cb1334ae29357e5f8511b"><gtr:id>2d35b264e78cb1334ae29357e5f8511b</gtr:id><gtr:otherNames>Liew CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1613-6071</gtr:issn><gtr:outcomeId>704F83EE102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB7FD505-A3D7-47C6-9D15-A900606F1CE0</gtr:id><gtr:title>PAX4 enhances beta-cell differentiation of human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d35b264e78cb1334ae29357e5f8511b"><gtr:id>2d35b264e78cb1334ae29357e5f8511b</gtr:id><gtr:otherNames>Liew CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>8F90311030F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAA69B87-EDE9-4702-A79D-D20D74046854</gtr:id><gtr:title>Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>F16B6F57BBD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58A9F705-50FD-4493-B96A-D5CDEA2A138B</gtr:id><gtr:title>Germ cells from mouse and human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7d39b148bebd378006c2b425ce30449"><gtr:id>e7d39b148bebd378006c2b425ce30449</gtr:id><gtr:otherNames>Aflatoonian B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>E3A5DC814EB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99710BD0-9330-40AA-8A6C-8501E89A4F18</gtr:id><gtr:title>Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.</gtr:title><gtr:parentPublicationTitle>Experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d88223709dcbfe8822d2418dbe9cf0fa"><gtr:id>d88223709dcbfe8822d2418dbe9cf0fa</gtr:id><gtr:otherNames>Vugler A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-4886</gtr:issn><gtr:outcomeId>B96D1D83132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9556DEB-7E71-4078-A0F2-7A24C596DB4E</gtr:id><gtr:title>Derivation of GMP raw materials for use in regenerative medicine: hESC-based therapies, progress toward clinical application.</gtr:title><gtr:parentPublicationTitle>Clinical pharmacology and therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/266ce29dfb2d2bb7b3ccbe48fd9b49f8"><gtr:id>266ce29dfb2d2bb7b3ccbe48fd9b49f8</gtr:id><gtr:otherNames>Hewitt ZA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-9236</gtr:issn><gtr:outcomeId>6CA2C90F388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E8F7F3-367B-4E4B-9DFC-2911AB801ACD</gtr:id><gtr:title>Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/725d10cb4b6c32ad5dbbb3f255c3d022"><gtr:id>725d10cb4b6c32ad5dbbb3f255c3d022</gtr:id><gtr:otherNames>Zafarana G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>E84415D6F9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AD9C602-7E4B-462F-96A6-B966F6D893A2</gtr:id><gtr:title>OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/712b646f22f8b7748126deeab49b3464"><gtr:id>712b646f22f8b7748126deeab49b3464</gtr:id><gtr:otherNames>Atlasi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>9E07543FB8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D6433E4-E3E3-4157-9558-6F8984BA9740</gtr:id><gtr:title>Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5595022016a4a1c3f702d2689191724"><gtr:id>a5595022016a4a1c3f702d2689191724</gtr:id><gtr:otherNames>Furue MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>B0735EEB366</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6706EC7B-04E0-4273-B7AC-DE23E593CA7C</gtr:id><gtr:title>Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay.</gtr:title><gtr:parentPublicationTitle>Molecular vision</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c73f01c778c6ba0f5bf0ad99ad99008"><gtr:id>6c73f01c778c6ba0f5bf0ad99ad99008</gtr:id><gtr:otherNames>Carr AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1090-0535</gtr:issn><gtr:outcomeId>17674AA5146</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300273</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>